Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Figs Soars As Wall Street Finds Its Apparel A Buy

Published 06/21/2021, 11:50 AM
Updated 06/21/2021, 11:52 AM
© Reuters.

© Reuters.

By Dhirendra Tripathi

Investing.com – Figs (NYSE:FIGS) shares rose almost 12.5% in Monday’s trading as buy calls from many brokerages buoyed sentiment for the stock.

Goldman Sachs (NYSE:GS), Credit Suisse (NYSE:CS), Morgan Stanley (NYSE:MS), KeyBanc, BofA Securities (NYSE:BAC), Cowen, Telsey Advisory, Oppenheimer (NYSE:OPY), Barclays (NYSE:BCS) and Piper Sandler were among the one who either put out a buy or an outperform rating on Figs' stock.

Figs is a direct-to-consumer healthcare apparel and lifestyle brand. The medical apparel company debuted last month, pricing its shares at $22 apiece.

Barclays’ Adrienne Yih has initiated coverage of the stock with an overweight rating and a $50 target, an upside of 22% from the stock’s current level of $41.

Figs is establishing the market for higher-end premium scrubs that are "perceived to be one-of-a-kind," Yih wrote in a research note.

KeyBanc analyst Edward Yruma sees the stock at $45. The analyst finds the company one of the most compelling growth stories in their coverage.

According to Piper Sandler’s Erinn Murphy, who has a $44 target for the stock, Figs is not only disrupting the $79 billion medical apparel market, but is also fueling the market as it accelerates its lifestyle offerings.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.